Cites,Authors,Title,Year,Source,Publisher,ArticleURL,CitesURL,GSRank,QueryDate,Type,DOI,ISSN,CitationURL,Volume,Issue,StartPage,EndPage,ECC,CitesPerYear,CitesPerAuthor,AuthorCount,Age,Abstract
0,"M.S. Keszler","Rehabilitation of Individuals with Limb Loss due to Trauma",2020,"Current Trauma Reports","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085327088&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85085327088&origin=inward",6,"2021-01-16 11:59:06","Review","10.1007/s40719-020-00193-8","2198-6096","https://api.elsevier.com/content/abstract/scopus_id/85085327088",6,2,96,104,0,0.00,0,1,1,""
8,"K. Potter-Baker","Reliability of TMS metrics in patients with chronic incomplete spinal cord injury",2016,"Spinal Cord","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962090359&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84962090359&origin=inward",5,"2021-01-16 11:59:06","Article","10.1038/sc.2016.47","1362-4393","https://api.elsevier.com/content/abstract/scopus_id/84962090359",54,11,980,990,8,1.60,8,1,5,""
10,"X. Hou","Combination of fasudil and celecoxib promotes the recovery of injured spinal cord in rats better than celecoxib or fasudil alone",2015,"Neural Regeneration Research","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84949462316&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84949462316&origin=inward",4,"2021-01-16 11:59:06","Article","10.4103/1673-5374.170314","1673-5374","https://api.elsevier.com/content/abstract/scopus_id/84949462316",10,11,1836,1840,10,1.67,10,1,6,""
15,"A. Shao","Emerging therapeutic targets associated with the immune system in patients with intracerebral haemorrhage (ICH): From mechanisms to translation",2019,"EBioMedicine","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067211347&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85067211347&origin=inward",3,"2021-01-16 11:59:06","Review","10.1016/j.ebiom.2019.06.012","2352-3964","https://api.elsevier.com/content/abstract/scopus_id/85067211347",45,,615,623,15,7.50,15,1,2,""
40,"R. Masgrau","Should We Stop Saying ‘Glia’ and ‘Neuroinflammation’?",2017,"Trends in Molecular Medicine","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85019033155&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85019033155&origin=inward",2,"2021-01-16 11:59:06","Review","10.1016/j.molmed.2017.04.005","1471-4914","https://api.elsevier.com/content/abstract/scopus_id/85019033155",23,6,486,500,40,10.00,40,1,4,""
320,"E. Hall","Neuroprotection and Acute Spinal Cord Injury: A Reappraisal",2004,"NeuroRx","","https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=17444392322&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=17444392322&origin=inward",1,"2021-01-16 11:59:06","Article","10.1602/neurorx.1.1.80","1545-5343","https://api.elsevier.com/content/abstract/scopus_id/17444392322",1,1,80,100,320,18.82,320,1,17,""
